Kusajili – Clinical trials directory

Result of your search per sponsor: Daniela Katz, MD

Woman and Man Max 99 years
Daniela Katz, MD Update Il y a 4 ans

A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma The purpose of this study is to determine whether ribociclib are effective and safe in the treatment of progressive well/dedifferentiated liposarcoma (WDL/DDL).

Country None
organs None
Specialty None

Closed trial

More information